デイリーニュース

Belgium and WHO reviewed their partnership, pledging deeper cooperation on universal health coverage, health‑system strengthening and equitable access to essential vaccines and medicines.

UCB Korea’s 1‑year Bimzelx launch conference emphasized shifting psoriasis goals from PASI75 to PASI100 and the drug’s IL‑17A/F dual inhibition as a disease‑modifying option.

WHO Director‑General Tedros Ghebreyesus and EIB Global Vice‑President Thomas Östros signed a €10 million grant to rebuild Lebanon’s Central Public Health Laboratory and support medication for over 50,000 chronic‑disease patients.

WHO coordinated advocacy actions across 100+ offices for World Health Day 2025's "Healthier beginnings, hopeful futures" theme.

GC Cell is broadening its cell‑therapy pipeline beyond oncology into autoimmune diseases, developing CAR‑NK, CAR‑T and NK cell products while leveraging stable cash flow from specimen testing.

The Korean Pharmaceutical Association announced the opening of its 4th Sports Pharmacist Expert Course to boost athlete protection, doping prevention, and medication counseling.

BridgeBio announced up to $1 billion in equity financing from Attruby, Sixth Street and HealthCare Royalty to support three upcoming medicines and its ATTR‑CM candidate.

Lonza announced expanded capacity for antibody‑drug conjugates and a broader partnership with a major U.S. drugmaker.

WHO Director-General Tedros praised philanthropic partners at the Philanthropy Asia Summit, emphasizing their role in health equity, vaccine access and universal coverage.

The WHO and African Union Commission signed an updated MoU at the 78th World Health Assembly, reaffirming joint commitments to health security, universal health coverage and health system strengthening across Africa.

WHO has certified Timor-Leste malaria‑free, the third nation in South‑East Asia to achieve this, after cutting cases from a 2006 peak of 223,000 to zero indigenous cases since 2021.

Korean community pharmacies are evolving beyond dispensing, integrating patient‑centered design, digital systems, branding and management practices, says pharmacist‑entrepreneur Yoon Seon‑chun.